Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,250 across all filing types
Latest filing 2019-07-30 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
2019年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the 2019 first extraordinary general meeting (临时股东大会) of 三诺生物传感股份有限公司. It includes information about the meeting date, voting methods (onsite and online), attendance, voting results on specific proposals, and legal opinions confirming the validity of the meeting and resolutions. There is no financial data or report content such as financial statements or management discussion. The document is clearly a formal announcement of voting results from a shareholder meeting, which fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 3,059 characters, which is consistent with a detailed voting results announcement rather than a full report or presentation.
2019-07-30 Chinese
第三届监事会第二十九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 29th meeting of the third Supervisory Board of the company SanNuo Biological Sensor Co., Ltd. It details the meeting date, attendees, agenda, and voting results regarding the unlocking of restricted stock incentives. The content is focused on board-level decisions and governance matters rather than financial results, audit opinions, or shareholder voting outcomes. It is not a full annual or interim report, nor is it a shareholder voting result announcement. The document fits best under Board/Management Information (MANG) as it relates to supervisory board resolutions and governance actions.
2019-07-26 Chinese
第三届董事会第三十六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a specific board meeting of the company 三诺生物传感股份有限公司, including details about the meeting date, attendees, and decisions made. It includes approval of a share acquisition and stock incentive plan matters. The document is titled as a board meeting resolution announcement and does not contain financial statements or detailed financial performance data. It is not an annual or interim report, nor an earnings release. It is not a regulatory filing or a report publication announcement since it contains substantive content about board decisions. Therefore, it fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management.
2019-07-26 Chinese
独立董事关于第三届董事会第三十六次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on matters discussed at the company's 36th board meeting of the third session, held on July 26, 2019. It includes independent opinions on a share acquisition transaction and the unlocking of restricted stock under a 2017 stock incentive plan. The document references compliance with regulatory guidelines and company bylaws, and it is signed by independent directors. The content is focused on board meeting matters and independent directors' opinions rather than a full annual report, audit report, or financial results. It is not a call transcript, earnings release, or capital update. The document is a formal board/management related announcement concerning governance and board decisions. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is short (1568 characters), and it contains substantive content rather than just an announcement or certification, so it is not RPA or RNS.
2019-07-26 Chinese
关于2017年限制性股票激励计划首次授予的第二个解锁期解锁条件成就的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement from a company regarding the achievement of conditions for the second unlocking period of a 2017 restricted stock incentive plan. It includes extensive information about the stock incentive plan, unlocking conditions, performance targets, individual performance assessments, and approvals from the board, supervisory committee, independent directors, and legal opinions. The document is not a financial report, earnings release, or regulatory filing in the usual sense, but rather a formal announcement about the unlocking of restricted shares under a stock incentive plan. It does not fit categories like Annual Report, Interim Report, or Earnings Release. It is not a simple announcement of voting results or a proxy statement. It is a corporate announcement related to management compensation and stock incentives. Given the specificity and nature of the content, the best fitting category is Regulatory Filings (RNS), as it is a formal regulatory announcement about stock incentive unlocking conditions and approvals, but not a remuneration report (DEF 14A) which typically details compensation amounts and policies. The document is over 8,000 characters and contains substantive content, so it is not a mere report publication announcement (RPA).
2019-07-26 Chinese
北京国枫律师事务所关于公司2017年限制性股票激励计划首次授予限制性股票第二次解锁相关事项的法律意见书
Regulatory Filings
2019-07-26 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.